Today at LSI, our CEO?Robert J. Krummen will share key insights on Vektor's leadership, commercial progress, innovation focus, and upcoming strategies for #vMap adoption and market growth. ?? Details: Today | 1:45 PM PT | LSI USA | Monarch Ballroom ?? #LSIUSA25 #medtech #cardiology
Vektor Medical, Inc.
医疗设备制造业
San Diego，California 7,231 位关注者
On a mission to revolutionize arrhythmia care.
关于我们
Vektor Medical is on a mission to revolutionize arrhythmia care. The FDA-cleared vMap technology, is an AI-based arrhythmia analysis tool, created to improve cardiac ablation outcomes, optimize workflows and increase procedural efficiency.
- 网站
-
https://www.vektormedical.com
Vektor Medical, Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- San Diego，California
- 类型
- 私人持股
- 创立
- 2017
- 领域
- Atrial Fibrillation、Electrophysiology、Ablation和aFib
地点
Vektor Medical, Inc.员工
动态
-
Today we announced key leadership appointments to support commercial expansion and market entry initiatives. Michael Andersen?has joined the company as?Vice President, Sales, and Mihir Naik?has been promoted to?Vice President, Quality Assurance and Regulatory Affairs. These key moves position Vektor for rapid growth following its?recently oversubscribed $25M Series A funding round. Additionally, our CEO?Robert J. Krummen?will present a?corporate update at LSI USA in Dana Point, California, on March 19 at 1:45 PM PST. The presentation will cover Vektor Medical’s?strengthened leadership, commercial momentum, and commitment to innovation - fueled by the $25M Series A funding round, led by TVM Capital Life Science and Solas BioVentures. Please join us in congratulating Mike and Mihir!
-
At Vektor, we're unlocking insights contained in a standard ECG. vMap, our AI-based arrhythmia analysis tool, was created to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. This is how we are moving cardiac care forward for patients and unlocking valuable insights for physicians. #medtech #cardiology #vMap #innovation
-
-
Patients need care. Change must happen to help EPs optimize workflows and improve outcomes. We're here to address the challenge. #vMap #medtech #cardiology
-
At Vektor, we’re committed to revolutionizing arrhythmia care; the closing of our oversubscribed Series A funding round is a major milestone that will accelerate commercialization?of our?FDA-cleared #vMap system, support?additional clinical studies, and drive?expansion into Europe—bringing our groundbreaking?AI-driven arrhythmia mapping technology?to more patients worldwide. ??If you are attending LSI USA, be sure to attend Rob’s presentation on March 19 to learn more about what’s next for Vektor.?? #LSIUSA25 #medtech #innovation #cardiology
Ahead of LSI USA, Vektor Medical, Inc. has successfully closed an oversubscribed $25 million Series A funding round, marking a major milestone in its mission to transform arrhythmia care. The round was led by LSI Alumni and leading life sciences investors, TVM Capital Life Science and Solas BioVentures. This infusion of capital will accelerate the commercialization of Vektor Medical’s innovative arrhythmia mapping technology, vMap, and support additional clinical studies, and drive expansion into the European market. Vektor Medical’s FDA-cleared vMAP system is the world’s first technology to accurately map arrhythmias using only the patient’s 12-lead ECG data. Clinicians upload ECG data into the vMap system, which then analyzes and visualizes the data, displaying a 3D map of arrhythmia sources. The vMap system accurately localizes arrhythmia sources in minutes to support and improve ablation treatment planning. Congratulations to LSI Alumni Robert J. Krummen and the entire Vektor Medical team on this major milestone! We’re also excited to welcome CEO Robert Krummen to LSI USA ‘25, where he’ll take the stage to present Vektor Medical. Join us March 17-21 in Dana Point, California, to connect with Robert and learn more about the company.
-
-
??“Good but not good enough. We can do so much more for patients. We can do so much more for doctors. The standard of care for treating arrhythmias just isn’t good enough. Every day, we ask ourselves how we can make it better.” ?? – Robert J. Krummen, CEO, Vektor Medical In this week’s??????????????????? ???????????????segment,?Vektor CEO Rob Krummen?shares what drives our relentless commitment to?revolutionizing arrhythmia care. True innovation comes from a passionate,?dedicated team that refuses to accept the status quo and is relentlessly focused on improving patient outcomes and changing lives. If you’re attending?LSI USA, don’t miss Rob’s presentation on?March 19, where he’ll dive deeper into how Vektor Medical is redefining the future of arrhythmia treatment. ?? Watch the full??????????????????? ?????????????? segment below. ?? #medtech #leadership #UnlockingInsight #LSIUSA25
-
?? Hello from Salt Lake City! Are you attending #WesternAFib? Stop by the Vektor booth to discover how vMap is transforming arrhythmia care with non-invasive, AI-driven mapping. ??????’?? ???????? ????. ?????????? ??????????????’?? ????????????????????????: ???????????????? ???? 8:40 ???? ?? Integrating AF Mapping into the PFA Ablation Procedure. See you there! #Cardiology #Electrophysiology #AFib
-
-
?? Milestone Achievement: 200 Cases with vMap! ?? Congratulations to Baptist Health System KY & IN — Dr. Gery Tomassoni, Rachelle Whitaker, Dr. Joel Simon, Dr. John Lee, and Dr. Johan D. Aasbo, DO, FACC, FHRS, on completing 200 vMap cases!! This achievement underscores the significant impact of AI-driven arrhythmia mapping in advancing patient care and optimizing cardiac ablation procedures. With 200 cases completed, Baptist Health continues to set the standard for innovation in electrophysiology! #vMap #cardiacinnovation #medtech #healthcarenews #patientcare
-
-
Good MedTech News?recently featured Vektor Medical Senior Advisor Marlou Janssen, discussing the future of?atrial fibrillation (AF) treatment?and how AI is reshaping ablation strategies. ?? Marlou highlights a significant challenge in AF ablation:?non-pulmonary vein AF drivers?are difficult to map with standard catheters and are often left untreated. vMap, the only FDA-cleared, non-invasive, AI-based arrhythmia analysis and localization tool designed to improve cardiac ablation procedures utilizing data from a standard 12-lead ECG, addresses this challenge by identifying patient-specific AF drivers and delivering a safe, effective, patient-centric approach. “This novel approach would be an enormous paradigm shift in the treatment of AF…” –?Marlou Janssen ?? ?? Read the full article:?https://lnkd.in/dm8rwRKm #AFib #medtech #ai #vMap #cardiology
-
Our CEO Robert J. Krummen has been selected to present at LSI USA on Wednesday, March 19 at 1:45 pm PT. If you are attending, add it to your schedule in the LSI partnering app and connect with Rob at the event! #LSIUSA25 #medtech #innovation #vMap
Vektor Medical, Inc. (#LSIUSA25 Innovator) is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Cardiac arrhythmias cause 10% of global deaths and over 25% of adults over 40 will develop a serious arrhythmia. Untreated arrhythmias not only raise the risk of death but are also associated with serious comorbidities such as stroke and dementia. Vektor Medical’s FDA-cleared vMAP system is the world’s first technology to accurately map arrhythmias using the patient’s 12-lead ECG data. Clinicians upload ECG data into the vMAP system, which then interprets and visualizes the data in 3D to identify sources of arrhythmia inside and outside of the heart. The vMAP system is capable of creating a "heat map" of the heart in minutes to support or improve ablation treatment planning. Vektor Medical had a very successful 2024 achieving many major milestones including: ? Raised $25M in Series A funding to expand operations, support clinical trials, and enhance product innovation. ? Expanded vMap adoption to over 1,500 cases across the U.S., with AF and AFL making up 46% of usage. ? Optimized mapping process for 2x faster speed and improved ventricular mapping accuracy. ? Launched the 60-Minute Mapping Key to support rapid arrhythmia assessments. ? Earned two of the Top 5 Abstracts at HRX 2025 for product innovation in multimodal capabilities. ? Secured Category III CPT Code 0897T for vMap reimbursement, effective July 1, 2024. We’re excited to announce that CEO, Robert J. Krummen has been selected to present Vektor Medical at LSI USA ‘25 this March 17-21. Join us in Dana Point, California to meet with Robert and learn more about Vektor Medical.
-